FORT LAUDERDALE, FL / ACCESSWIRE / November 11, 2022 / The lights seemed to shine bright on Liquivida at the first-ever IV BizBash last month in Orlando where Samael Tejada, president and founder, ...

NexGen Health in San Jose has launched a physician-led Cerebrolysin IV Therapy Program, offering advanced neurological support through a personalized 10-treatment protocol. Designed to aid patients ...

Phase I, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered Ad5CMV-p53, an Adenoviral Vector Containing the Wild-Type p53 Gene, in Patients With Advanced Cancer UFT+LV achieved ...

SAFE Initiative: A step closer to a positive safety culture and improved patient experience. This is an ASCO Meeting Abstract from the 2018 Quality Care Symposium. This abstract does not include a ...

The Annals of Pharmacotherapy. 2009;43(9):1413-1418. Oeyen et al. [11] prospectively followed 30 ICU patients receiving intensive insulin therapy per a paper-based, fixed-dose protocol (goal 81–110 mg ...

Background: Hyperglycemia is common in critically ill patients and is an independent risk factor for in-hospital morbidity and mortality. Objective: To assess compliance with a paper-based, ...